Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin and cerebral pain processing in painful diabetic neuropathy
2006-005630-21Phase 4Terminated
- Sponsor
- University of Birmingham
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of pregabalin in diabetic neuropathy, diabetes mellitus type 1 (T1D) and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by University of Birmingham. Primary endpoints: Change in pain-related brain activity at rest, Change in pain-related brain activity during noxious thermal stimulation and 4 more. Started Apr 2009; status: terminated.
02
Drugs
pregabalin
03
Conditions
diabetic neuropathydiabetes mellitus type 1 (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2006-005630-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005630-21.